3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra

Journal of Neurochemistry

Volumn 69, Issue 4, 1997, Pages 1684-1692

  Elverfors, Anders ^a   Pileblad, Erik ^a   Lagerkvist, Sören ^a   Bergquist, Filip ^a   Jonason, Jan ^a   Nissbrandt, Hans ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

3 Methoxy tyramine; Catechol O methyltransferase; Dopamine; Microdialysis; Striatum; Substantia nigra

Indexed keywords

3 O METHYLDOPAMINE; AMINE OXIDASE (FLAVIN CONTAINING); CATECHOL METHYLTRANSFERASE; DOPAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ALIA; ANIMALIA;

EID: 0030985409     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69041684.x     Document Type: Article

References (47)

1. Andén N.-E. (1980) Regulation of monoamine synthesis and utilisation by receptors, in Handbook of Experimental Pharmacology, Vol. 27 (Szekeres L., ed), pp. 429-462. Springer-Verlag, Berlin/New York.
2. Benveniste H. (1989) Brain microdialysis. J. Neurochem. 52, 1667-1679.
3. Bjijou Y., Stinus L., Le Moal M., and Cador M. (1996) Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intraventral tegmental area injections of d-amphetamine. J. Pharmacol. Exp. Ther. 277, 1177-1187.
4. Cameron D. L. and Williams J. T. (1993) Dopamine D1 receptors facilitate transmitter release. Nature 236, 344-347.
5. 3H]-serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine. J. Pharmacol. Exp. Ther. 267, 379-389.
6. Dedek J., Baumes R., Tien-Duc N., Gomeni R., and Korf J. (1979) Turnover of free and conjugated (sulphonyloxy) dihydroxyphenylacetic acid and homovanillic acid in rat striatum. J. Neurochem. 33, 687-695.
7. Della Corte L. and Tipton K. F. (1980) The turnover of the A- and B-forms of monoamine oxidase in rat liver. Biochem. Pharmacol. 29, 891-895.
8. Elverfors A. and Nissbrandt H. (1991) Reserpine insensitive dopamine release in the substantia nigra? Brain Res. 557, 5-12.
9. Elverfors A. and Nissbrandt H. (1992) Effects of d-amphetamine on dopaminergic neurotransmission: a comparison between the substantia nigra and the striatum. Neuropharmacology 31, 661-670.
10. Engberg G., Elverfors A., Jonason J., and Nissbrandt H. (1996) Dopamine re-uptake inhibition: significance for nigral dopamine activity. Synapse 25, 215-226.
11. Fadda F., Argiolas A., Stefanini E., and Gessa G. L. (1977) Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus. Life Sci. 21, 411-418.
12. Geffen L. B., Jessell T. M., Cuello A. C., and Iversen L. L. (1976) Release of dopamine from dendrites in rat substantia nigra. Nature 260, 258-260.
13. Heeringa M. J. and Abercrombie E. D. (1995) Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release. J. Neurochem. 65, 192-200.
14. Hurd Y. L. and Ungerstedt U. (1989) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in caudate-putamen. Eur. J. Pharmacol. 166, 251-260.
15. Imperato A. and Di Chiara G. (1984) Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J. Neurosci. 4, 966-977.
16. Iravani M. M., Muscat R., and Kruk Z. L. (1996) Comparison of some somatodendritic and axon terminal dopamine release in the ventral tegmental area and the nucleus accumbens. Neuroscience 70, 1025-1037.
17. Jonason J. and Rutledge C. O. (1968) The effect of protriptyline on the metabolism of dopamine and noradrenaline in rabbit brain in vitro. Acta Physiol. Scand. 73, 161-175.
18. Kalivas P. W. and Duffy P. (1991) A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J. Neurochem. 56, 961-967.
19. Kalivas P. W. and Stewart J. (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16, 223-244.
20. Kastner A., Anglade P., Bounaix C., Damier P., Javoy-Agid F., Bromet N., Agid Y., and Hirsch E. C. (1994) Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system. Neuroscience 62, 449-457.
21. Kebabian J. W., Saavedra J. M., and Axelrod J. (1977) A sensitive enzymatic-radioisotopic assay for 3,4-dihydroxyphenylacetic acid. J. Neurochem. 28, 795-801.
22. Kehr W. (1976) 3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 293, 209-215.
23. Kelly E., Jenner P., and Marsden C. D. (1984) Behavioural effects mediated by unilateral nigral dopamine receptor stimulation in the rat. Exp. Brain Res. 55, 243-252.
24. Lagerkvist S. (1991) Sample splitting provides a fast and selective method for determining brain dialysate dopamine and its metabolites, in Monitoring Molecules in Neuroscience (Rollema H., Westerink B., and Drijhout W. J., eds), pp. 136-138. Krips Repo, Meppel, The Netherlands.
25. LaHoste G. J. and Marshall J. F. (1990) Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists. Behav. Brain Res. 38, 233-242.
26. Magnusson O., Mohringe B., and Fowler C. J. (1987) Comparison of the effects of dopamine D 1 and D 2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilization. J. Neural Transm. 69, 163-177.
27. Moghaddam B. and Bunney B. S. (1989) Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J Neurochem. 53, 652-654.
28. Nieoullon A., Chéramy A., and Glowinski J. (1977) Release of dopamine in vivo from cat substantia nigra. Nature 266, 375-377.
29. Nirenberg M. J., Chan J., Liu Y., Edwards R. H., and Pickel V. M. (1996) Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J. Neurosci. 16, 4135-4145.
30. Nissbrandt H. and Carlsson A. (1987) Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra. J. Neurochem. 49, 959-967.
31. Nissbrandt H., Sundström E., Jonsson G., Hjorth S., and Carlsson A. (1989) Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacta, pars reticulata, and striatum. J. Neurochem. 52, 1170-1182.
32. Nissbrandt H., Engberg G., and Pileblad E. (1991) The effects of GBR 12909, a dopamine reuptake inhibitor on catecholaminergic neurotransmission in substantia nigra, striatum, limbic forebrain and cortical hemispheres. Naunyn Schmiedebergs Arch. Pharmacol. 344, 16-28.
33. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
34. Robertson G. S., Damsma G., and Fibiger H. C. (1991) Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J. Neurosci. 11, 2209-2216.
35. Robinson T. E. and Berridge K. C. (1993) The neuronal basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247-291.
36. Santiago M. and Westerink B. H. C. (1990) Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn Schmiedebergs Arch. Pharmacol. 342, 407-414.
37. Santiago M. and Westerink B. H. C. (1991) Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. J. Neurochem. 57, 738-747.
38. Timmerman W. and Abercrombie E. D. (1996) Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects. Synapse 23, 280-291.
39. Tonon G., Saiani L., Spano P. F., and Trabucchi M. (1979) Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus. Brain Res. 160, 553-558.
40. Vezina P. (1996) D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J. Neurosci. 16, 2411-2420.
41. Waters N., Lagerkvist S., Löfberg L., Piercey M., and Carlsson A. (1993) The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study. Eur. J. Pharmacol. 242, 151-163.
42. Westerink B. H. C. (1979) Effects of drugs on the formation of 3-methoxy-tyramine, a dopamine metabolite, in the substantia nigra, striatum, nucleus accumbens and tuberculum olfactorium of the rat. J. Pharm. Pharmacol. 31, 94-99.
43. Westerink B. H. C. (1995) Brain microdialysis and its application for the study of animal behaviour. Eur. J. Pharmacol. 242, 151-163.
44. Westerink B. H. C. and Korf J. (1976) Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain. Eur. J. Pharmacol. 37, 249-255.
45. Wilk S., Watson E., and Travis B. (1975) Evaluation of dopamine metabolism in rat striatum by a gas chromatographic technique. Eur. J. Pharmacol. 30, 238-243.
46. Zetterström T. and Ungerstedt U. (1984) Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis. Eur. J. Pharmacol. 97, 29-36.
47. Zetterström T., Sharp T., and Ungerstedt U. (1985) Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur. J. Pharmacol. 106, 27-37.